Ionis Pharmaceuticals is a biopharmaceutical company based in California that discovers and develops medicines using antisense technology, which is designed to target RNA and reduce or modify the production of disease-causing proteins. Its products and pipeline address rare genetic disorders, neurological conditions, and cardiovascular and metabolic diseases. The company works with partners in the pharmaceutical industry to develop and commercialise some of its medicines, and it also advances its own therapies through clinical development.
Ionis Pharmaceuticals, Inc. trades under the code 0JDI on the London Exchange in UK, with its price quoted in US dollars (USD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Weak price profile
Ranks #3515 of 3787 on the London Exchange · confidence Medium
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for UK yet.
TrendWeak
8/100
Below its long-term averages and far from its highs.
See the numbers →
Above 200-day average-36.5%
From 52-week high-50.2%
MomentumWeak
8/100
Lagging most stocks on this exchange.
See the numbers →
3-month return-23.5%
6-month return-42.5%
Stability (higher is calmer)Weak
27/100
Volatile, with deep drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)44.8%
Worst drawdown, 1 year (smaller is calmer)-50.6%
LiquidityWeak
31/100
Thinly traded: prices can jump and exits can be hard.
See the numbers →
Avg daily value traded0.10M USD
Zero-volume days0.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for UK when fundamentals data for this market is added. All UK stocks.
52-wk range 42.05 – 86.74Daily closes, split-adjusted
Signals
50-day average50.63
200-day average67.68
Golden/death cross (60d)None
New 52-week highNo
Bullish RSI divergenceYes
Average daily range (ATR)2.17
Technical summary
Daily
Strongly bearish
2 bullish · 2 neutral · 11 bearish
Weekly
Strongly bearish
1 bullish · 0 neutral · 6 bearish
Monthly
Strongly bearish
0 bullish · 0 neutral · 1 bearish
Moving averages (daily)
SMA 10
43.74
Bearish
EMA 10
43.93
Bearish
SMA 20
44.16
Bearish
EMA 20
44.83
Bearish
SMA 50
50.63
Bearish
EMA 50
49.40
Bearish
SMA 100
58.29
Bearish
EMA 100
55.97
Bearish
SMA 200
67.68
Bearish
EMA 200
–
n/a
Oscillators (daily)
RSI (14)
38.09
Neutral
MACD (12, 26)
-1.63
Bearish
Momentum (12)
-1.85
Bearish
Stochastic %K (14)
16.54
Bullish
Williams %R (14)
-83.46
Bullish
CCI (20)
-51.30
Neutral
Pivot points (classic, last session)
S3
39.18
S2
40.92
S1
41.93
Pivot
43.67
R1
44.68
R2
46.42
R3
47.43
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in USD. Educational only, not financial advice.
